ClinicalTrials.gg

Knoa Pharma clinical trials

What moves in its pipeline, every Monday. Free with an account during the beta.

The registry lists 73 studies whose lead sponsor is Knoa Pharma or one of 3 companies grouped under it. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 7, 2026.

Our grouping of 4 registry names, not the registry’s. See them and correct one ↓

Pipeline: 2 programs

Each counted once: 2 with a study Knoa Pharma leads registered in the last two years.

  • Phase 1
  • Phase 4 (approved, new studies)

The 2 programs — sign in to see the list, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Knoa Pharma’s own registered studies; Knoa Pharma’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Knoa Pharma’s studies test, most studies first; none is open now — 13 drugs with a page of their own. Each count opens the studies in search.

Studies, none open

Show 3 more

All 73 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Completed5778%
  • Stopped early1521%Terminated 12 · Withdrawn 3
  • Status unknown or other11%

Phase

  • Phase 336
  • Phase 119
  • Phase 211
  • Phase 47

Where

  • United States69
  • Canada3
  • Romania2
  • New Zealand2
  • United Kingdom2
  • Israel2

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 1011
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 126

By the year each study started; 23 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Knoa Pharma.

  • Purdue Pharma LP
    Acquired — became part of Knoa Pharma, May 1, 2026 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    58 studies →
  • Rhodes Pharmaceuticals, L.P.
    Acquired — became part of Knoa Pharma, May 1, 2026 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    11 studies →
  • Knoa Pharma LLC
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies
  • Purdue Frederick
    Acquired — became part of Knoa Pharma, May 1, 2026 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions Knoa Pharma leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 73. Browse all 73 →